Control of cholesterol-induced adipocyte inflammation by the Nfe2l1-Atf3 pathway
Carolin Jethwa,Anne Hoffmann,Stefan Kotschi,Janina Caesar,Matthias Kern,Anna Worthmann,Christian Schlein,Sajjad Khani,Bernardo A Arús,Oliver T Bruns,Adhideb Ghosh,Christian Wolfrum,Yvonne Döring,Stephan Herzig,Christian Weber,Matthias Blüher,Scott B Widenmaier,Gökhan S Hotamışlıgil,Alexander Bartelt
DOI: https://doi.org/10.1101/2024.07.22.604614
2024-07-23
Abstract:While adipocytes are critical pillars of energy metabolism, their dysfunction is linked to adipose tissue (AT) inflammation, insulin resistance, and ectopic lipotoxicity in cardiometabolic diseases. However, the mechanisms causing adipocyte inflammation and insulin resistance remain unclear. Here, we show that excess cholesterol induces adipocyte dysfunction, which is suppressed by the transcription factor Nfe2l1 (nuclear factor erythroid derived-2, like-1). Nfe2l1 is required to sustain proteasome function in adipocytes and proteotoxic stress induces adipocyte inflammation via the activation of Atf3. In humans, the Nfe2l1-proteasome pathway is inversely correlated to body mass index (BMI) in an adipose-depot specific manner. In mice, loss of adipocyte Nfe2l1 caused AT inflammation with a pronounced infiltration of macrophages and T cells. Mice lacking adipocyte Nfe2l1 displayed severe adipocyte dysfunction during diet-induced obesity (DIO), characterized by lower adipokine levels, steatosis, glucose intolerance and insulin resistance. Nfe2l1∆AT mice on an Apoe-deficient (Apoe KO) background fed a cholesterol-rich Western Diet (WD), developed a lipoatrophy-like syndrome, dyslipidemia, and enhanced atherosclerosis. Our results reveal an important role for proteasome-mediated proteostasis in adipocytes and indicate that Nfe2l1 is linked to metabolic health in humans and preclinical mouse models. Promoting proteostasis in adipocytes may thus alleviate inflammation in obesity, potentially averting adverse cardiometabolic outcomes.
Physiology